Cleared Traditional

K231498 - TraumaCad Neo (FDA 510(k) Clearance)

Nov 2023
Decision
180d
Days
Class 2
Risk

K231498 is an FDA 510(k) clearance for the TraumaCad Neo. This device is classified as a System, Image Processing, Radiological (Class II - Special Controls, product code LLZ).

Submitted by Brainlab , Ltd. (Petach-Tikva, IL). The FDA issued a Cleared decision on November 20, 2023, 180 days after receiving the submission on May 24, 2023.

This device falls under the Radiology FDA review panel. Regulated under 21 CFR 892.2050.

Submission Details

510(k) Number K231498 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 24, 2023
Decision Date November 20, 2023
Days to Decision 180 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF

Device Classification

Product Code LLZ - System, Image Processing, Radiological
Device Class Class II - Special Controls
CFR Regulation 21 CFR 892.2050